Search for: "September Productions, Inc. v. Doe 1 et al" Results 121 - 140 of 171
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2008, 4:30 am
: (IAM), (Patent Circle), India takes open source approach to drug discovery: (Patent Lens), India: Indian Bayh Dole Bill: (Spicy IP), (Spicy IP), (Does India need Bayh-Dole? [read post]
27 Apr 2022, 1:12 pm by Public Employment Law Press
Decided on April 27, 2022 No. 60 [*1]In the Matter of Tim Harkenrider, et al., Respondents-Appellants, vKathy Hochul, & c., et al., Appellants-Respondents, et al., Respondents. [read post]
27 Apr 2022, 1:12 pm by Public Employment Law Press
Decided on April 27, 2022 No. 60 [*1]In the Matter of Tim Harkenrider, et al., Respondents-Appellants, vKathy Hochul, & c., et al., Appellants-Respondents, et al., Respondents. [read post]
8 Mar 2018, 11:35 am by Ad Law Defense
”  Organic Consumers Association et al v. [read post]
27 Oct 2014, 5:27 am
The case concerns the alleged infringement of a colour trade mark for yellow by a business that distributes language learning software using yellow on product packaging and advertisements. [read post]
25 Oct 2022, 10:46 am by assoulineberlowe
The Hydrogen Technology Corporation et al In the Southern District of New York, the SEC brought another civil action. [read post]
9 Aug 2008, 1:50 am
: (Techdirt), Microsoft Research launches new tools for knowledge sharing: (creativecommons.org), Yet another star singer, Duffy, doesn’t mind file-sharing: (Techdirt)   Events 20 August – Bill Patry speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry speaking on copyright – Sydney:… [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
Four Myths about Biotech Securities Cases   As discussed in our original article, these findings overturn several longstanding myths about this subset of securities class actions:   Myth #1: Cases against biotech companies for failed clinical trials or products that are not approved by the FDA are risky and expensive. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex… [read post]
11 Jan 2023, 9:51 am by Karina Lytvynska
A year-long subscription is $35.99.[9] How does AI create the avatars? [read post]
24 Jul 2011, 2:38 pm by R Grace Rodriguez
 READ BELOW FOR THE WHOLE DECISION 2011 WL 2612835Only the Westlaw citation is currently available.California Rules of Court, rule 8.1115, restricts citation of unpublished opinions in California courts.Court of Appeal, Fifth District, California.Mark DEMUCHA et al., Plaintiffs and Appellants,v.WELLS FARGO HOME MORTGAGE INC., Defendant and Respondent.No. [read post]
6 May 2015, 7:09 pm by Jon Gelman
In addition, SSDI benefits are only provided to workers with permanent and total disabilities.1 In contrast, workers’ compensation benefits are provided for both permanent total and permanent partial disability. [read post]
19 Sep 2017, 3:55 pm by Kevin LaCroix
  Every targeted plan had more than $1 billion in plan assets. [read post]